Horie Hidenori, Kadoya Toshihiko
Advanced Research Center for Biological Science, Waseda University, Tokyo 202-0021, Japan.
Glycoconj J. 2002;19(7-9):479-89. doi: 10.1023/B:GLYC.0000014077.84016.52.
Previous data have suggested that galectin-1 is expressed widely in nervous tissues at embryonic stages but becomes restricted mainly to peripheral nervous tissues with maturation. Though the expression is intense in adult mammalian peripheral neurons, there had been no report about functions of galectin-1 there. Recently we discovered a factor that enhanced peripheral axonal regeneration. The factor was identified as oxidized galectin-1 with three intramolecular disulfide bonds and showed no lectin activity. Oxidized recombinant human galectin-1 (rhGAL-1/Ox) showed the same nerve growth promoting activity at very low concentrations (pg/ml). rhGAL-1/Ox at similarly low concentration was also effective in in vivo experiments of axonal regeneration. Moreover, the application of functional anti-rhGAL-1 antibody strongly inhibited the axonal regeneration in vivo as well as in vitro. Since galectin-1 is expressed in the regenerating sciatic nerves as well as in both sensory neurons and motor neurons, these results suggest that galectin-1 is secreted into the extracellular space to be oxidized, and then, in its oxidized form, to regulate initial repair after axotomy. The administration of oxidized galectin-1 effectively promoted functional recovery after sciatic nerve injury in vivo. Oxidized galectin-1, hence, appears to play an important role in promoting axonal regeneration, working as a kind of cytokine, not as a lectin. Recent reports indicated additional roles of cytosolic galectin-1 in neural diseases, such as ALS. Furthermore galectin-1 has been proved to be a downstream target of DeltaFosB. In hippocampus of rat brain, expression of DeltaFosB is induced immediately after ischemia-reperfusion, suggesting that galectin-1 may also play important roles in central nervous system after injury.
先前的数据表明,半乳糖凝集素-1在胚胎期的神经组织中广泛表达,但随着成熟主要局限于周围神经组织。虽然在成年哺乳动物的周围神经元中表达强烈,但此前尚无关于半乳糖凝集素-1在那里功能的报道。最近我们发现了一种促进周围轴突再生的因子。该因子被鉴定为具有三个分子内二硫键的氧化型半乳糖凝集素-1,且无凝集素活性。氧化型重组人半乳糖凝集素-1(rhGAL-1/Ox)在非常低的浓度(pg/ml)下就表现出相同的神经生长促进活性。同样低浓度的rhGAL-1/Ox在轴突再生的体内实验中也有效。此外,功能性抗rhGAL-1抗体的应用在体内和体外都强烈抑制了轴突再生。由于半乳糖凝集素-1在再生的坐骨神经以及感觉神经元和运动神经元中均有表达,这些结果表明半乳糖凝集素-1分泌到细胞外空间被氧化,然后以其氧化形式调节轴突切断后的初始修复。氧化型半乳糖凝集素-1的给药在体内有效促进了坐骨神经损伤后的功能恢复。因此,氧化型半乳糖凝集素-1似乎在促进轴突再生中起重要作用,作为一种细胞因子而非凝集素发挥作用。最近的报道表明胞质半乳糖凝集素-1在神经疾病如肌萎缩侧索硬化症中有其他作用。此外,半乳糖凝集素-1已被证明是DeltaFosB的下游靶点。在大鼠脑海马中,缺血再灌注后立即诱导DeltaFosB的表达,这表明半乳糖凝集素-1在中枢神经系统损伤后可能也起重要作用。